ProKidney Corp. (PROK)

NASDAQ

$1.45

$+0.05

(+3.58%)

Previous Close: ⁦$1.40⁩

Market Closed

ProKidney Corp. (PROK) Live Price Chart

Last updated: ⁦2026-10-21 03:59:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

ProKidney Corp. (PROK) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.45, with a market capitalization of $277.87M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.30 to $3.48. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$277.87M
Open	$1.40
Day's High	$14.19
Day's Low	$0.46
Previous Close	$1.40
Volume	1.31M
Average Volume	1.31M
P/E Ratio	--
52-Week High	$3.48
52-Week Low	$1.30
Dividend Yield	--
Earnings Date	--

ProKidney Corp. (PROK) Latest Closing Stock Price

ProKidney Corp. (PROK) last closed at $1.40 as of 2026-10-20 23:44:00, unchanged from the previous close of $1.40.

During the latest regular trading session, PROK traded between $0.46 and $14.19, with a volume of 1.31M shares. The closing price was near the lower end and near the lower end of its 52-week range.

ProKidney Corp. (PROK) 7-Day Stock Price Change

Over the past seven days, ProKidney Corp. (PROK) moved from $1.74 to $1.45, representing a decline of 16.84% ($0.29).

The stock traded between $1.31 and $1.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.35 million shares, up versus the previous seven-day period, indicating higher trading activity.

PROK 52-Week Price Position

Position in Range: 6.7%

52W Low$1.30

52W High$3.48

PROK is currently trading at $1.45, placing it 6.7% of the way from its 52-week low of $1.30 to its 52-week high of $3.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ProKidney Corp. (PROK)?

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

ProKidney Corp. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	231
Exchange	NASDAQ
Company Website	https://www.prokidney.com

How to Buy ProKidney Corp. (PROK) Stock on MEXC

Eligible investors can buy real shares of ProKidney Corp. (PROK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PROK and Place Your Order

Open the RealStocks trading page and search for PROK. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ProKidney Corp. (PROK) stock price today?

ProKidney Corp. (PROK) is currently trading at $ 1.45, up 3.73% ($0.05) from the previous close of $ 1.40. Intraday prices update in real time during regular trading hours.

2.Is PROK stock going up or down today?

As of 2026-10-20 23:44:00, PROK is trading at $ 1.45, up 3.73% ($0.05) from its previous close of $ 1.40. The stock has traded between $ 0.46 and $ 14.19 during today’s regular session. Past price movements do not guarantee future results.

3.What is PROK pre-market price?

As of 2026-10-20 23:44:00, PROK is trading at $ 1.40 in pre-market trading, unchanged from the previous close of $ 1.40. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PROK after-hours price?

As of 2026-10-20 23:44:00, PROK is trading at $ 1.44 in after-hours trading, up 3.30% ($0.05) from the regular-session close of $ 1.40. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PROK stock trading now?

PROK trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PROK sit relative to its 52-week high and low?

Over the past 52 weeks, PROK has traded between a low of $ 1.30 and a high of $ 3.48. At $ 1.45, the stock is positioned 6.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ProKidney Corp. in?

ProKidney Corp. (PROK) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ProKidney Corp.'s market capitalization and where is it listed?

ProKidney Corp. is listed on the NASDAQ exchange with a market capitalization of $ 277.87M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PROK valued in terms of P/E ratio and EPS?

PROK trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.40. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ProKidney Corp. pay a dividend?

ProKidney Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.